Related Experiment Video
Updated: Jun 2, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory
Faroudy Boufassa1, Asier Saez-Cirion, Jérome Lechenadec
1Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of HIV and STI Team, Le Kremlin-Bicêtre, France. faroudy.boufassa@inserm.fr
Insights
Viral blips in HIV controllers correlate with declining CD4 T cells and increased risk of health issues, suggesting chronic inflammation. Long-term undetectable viral load is key for HIV management.
Area of Science:
- Immunology
- Virology
- Public Health
Background:
- Few large studies exist on HIV controllers with sustained undetectable viral load (VL).
- This study examines 81 French HIV controllers with long-term suppressed HIV RNA.
- HIV controllers represent a small fraction (0.31%) of patients in French hospitals.
Purpose of the Study:
- To characterize French HIV controllers.
- To investigate the impact of viral blips on CD4 T cell counts and clinical outcomes.
Main Methods:
- Defined HIV controllers as asymptomatic, treatment-naïve individuals with >10 years of infection and >90% undetectable VL.
- Analyzed CD4 cell count slopes using mixed-effect linear models.
- Compared outcomes between controllers with no blips, rare blips, and frequent blips.
Main Results:
- Intravenous drug use was overrepresented, and homosexual men underrepresented among these controllers.
- CD4 cell counts remained stable in those with no viral blips.
- Significant CD4 T cell decline occurred in controllers with rare or frequent viral blips.
Conclusions:
- Viral blips in HIV controllers are linked to CD4 T cell decline.
- Blips may increase the risk of clinical events and cancers, potentially due to chronic inflammation.
Background:
There are few large published studies of HIV controllers with long-term undetectable viral load (VL). We describe the characteristics and outcomes of 81 French HIV controllers.
Methods And Results:
HIV controllers were defined as asymptomatic, antiretroviral-naïve persons infected ≥10 years previously, with HIV-RNA <400 copies/mL in >90% of plasma samples. All available CD4 and VL values were collected at enrolment. Mixed-effect linear models were used to analyze CD4 cell count slopes since diagnosis. HIV controllers represented 0.31% of all patients managed in French hospitals. Patients infected through intravenous drug use were overrepresented (31%) and homosexual men were underrepresented (26% of men) relative to the ANRS SEROCO cohort of subjects diagnosed during the same period. HIV controllers whose VL values were always below the detection limit of the assays were compared with those who had rare "blips" (<50% of VL values above the detection limit) or frequent blips (>50% of VL values above the detection limit). Estimated CD4 cell counts at HIV diagnosis were similar in the three groups. CD4 cell counts remained stable after HIV diagnosis in the "no blip" group, while they fell significantly in the two other groups (-0.26√CD4 and -0.28√CD4/mm(3)/year in the rare and frequent blip groups, respectively). No clinical, immunological or virological progression was observed in the no blip group, while 3 immunological and/or virological events and 4 cancers were observed in the blip subgroups.
Conclusions:
Viral blips in HIV controllers are associated with a significant decline in CD4 T cells and may be associated with an increased risk of pathological events, possibly owing to chronic inflammation/immune activation.
Related Concept Videos
Retrovirus Life Cycles
Retroviruses

